Alimera Sciences Inc. - notizie pubblicate 237 - letture 2.927
ALIMERA SCIENCES INC.
Quarterly Report for Quarter Ending June 30, (Form 10-Q)
Table of contents united states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) x quarterly report pursuant to section 13 or 15(d) of the securities ...
ALIMERA SCIENCES INC.
Alimera Sciences Reports Second Quarter 2023 Results - Form 8-K
Alimera sciences reports secondquarter 2023 results · alimera acquired u.s.commercial rights toyutiq® · landmark new day studycompleted enrollment with over 300 patients · ...
ALIMERA SCIENCES INC.
Initial Statement of Beneficial Ownership - Form 3
Form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section 16(a) of the securit ...
ALIMERA SCIENCES INC.
Statement of Changes in Beneficial Ownership - Form 4
Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...
ALIMERA SCIENCES INC.
Private Placement - Form 8-K
Alim-20230801x8k united states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1 ...
ALIMERA SCIENCES INC.
Supplemental Prospectus - Form 424B3
Filed pursuant to rule 424(b)(3) registration no. 333-273090 alimera sciences, inc. prospectus supplement no. 1 to prospectus dated july 12, 2023 this prospectus supplement no. 1 s ...
ALIMERA SCIENCES INC.
Notice of Effectiveness - Form EFFECT
United states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: july 12, 2023 4:00 p.m. form: s-3 cik: 0001267602 company name: ...
ALIMERA SCIENCES INC.
Supplemental Prospectus - Form 424B3
Filed pursuant to rule 424(b)(3) registration no. 333-273090 prospectus alimera sciences, inc. up to 49,763,960 shares of common stock this prospectus relates to the re ...
ALIMERA SCIENCES INC.
Registration Statement - Specified Transactions - Form S-3
As filed with the securities and exchange commission on june30, 2023 registration no. 333- united states securities and exchange commission washington, d.c. 20549 _________________ ...
ALIMERA SCIENCES INC.
Proxy Statement - Form DEF 14A
United states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of ...
ALIMERA SCIENCES INC.
Management Change - Form 8-K
Alim-20230628x8k united states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1 ...
ALIMERA SCIENCES INC.
Preliminary Proxy Statement - Form PRE 14A
United states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of ...
ALIMERA SCIENCES INC.
Current Report - Form 8-K
Alim-20230607x8k united states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1 ...
ALIMERA SCIENCES INC.
Amendment to Notice of Sales of Unregistered Securities - Form D/A
The securities and exchange commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. the reader should not assu ...
ALIMERA SCIENCES INC.
Statement of Changes in Beneficial Ownership - Form 4
Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti